Efficacy and safety of different traditional Chinese medicine injections in the treatment of unstable angina pectoris: a systematic review and Bayesian network meta-analysis
Efficacy and safety of different traditional Chinese medicine injections in the treatment of unstable angina pectoris: a systematic review and Bayesian network meta-analysis
Chen et al., 2025 | Front Pharmacol | Systematic Review
Citation
Chen Qiuhan, Wang He, ... Zhou Yabin. Efficacy and safety of different traditional Chinese medicine injections in the treatment of unstable angina pectoris: a systematic review and Bayesian network meta-analysis. Front Pharmacol. 2025;16:1550759. doi:10.3389/fphar.2025.1550759
Abstract
OBJECTIVES: Several studies have explored the efficacy and safety of various traditional Chinese medicine (TCM) injections for unstable angina pectoris. However, comprehensive systematic evidence confirming the advantages of these injections is still lacking. This Bayesian network meta-analysis was carried out to evaluate and compare the efficacy of different TCM injections in treating unstable angina pectoris. METHODS: A systematic search was implemented across PubMed, Cochrane Library, Embase, and Web of Science, with the date of search cutoff being February 2024. The Cochrane risk of bias tool was utilized to evaluate the bias risk in the included studies. RESULTS: A total of 44 studies, encompassing 4,362 patients with unstable angina pectoris and 21 types of injections, were included. Compared with the standard treatment group, Danhong injection (SMD = -1.1, 95% CrI: -2.0, -0.15), Danshen Chuanxiongqin injection (SMD = -1.9, 95% CrI: -3.7, -0.12), Ginkgo Damole injection (SMD = -2.5, 95% CrI: -4.8, -0.29), Puerarin injection (SMD = -1.8, 95% CrI: -3.2, -0.37), and Shuxuetong injection (SMD = -7.8, 95% CrI: -13, -2.3) were found to significantly reduce the frequency of angina attacks. However, no significant improvement was observed in the duration of angina episodes with any of the included TCM injections compared with the standard treatment group. There was no significant difference in the incidence of adverse events from TCM injections. CONCLUSION: Adjunctive treatment with TCM injections, in addition to conventional therapy, can remarkably reduce the frequency of angina attacks and demonstrates a favorable safety profile. However, it does not appear to significantly reduce the duration of angina episodes. Future studies should include more multicenter populations to validate our conclusions, as the population included in this study was predominantly Chinese. SYSTEMATIC REVIEW REGISTRATION: identifier [CRD42024501984].
Key Findings
A total of 44 studies, encompassing 4,362 patients with unstable angina pectoris and 21 types of injections, were included. Compared with the standard treatment group, Danhong injection (SMD = -1.1, 95% CrI: -2.0, -0.15), Danshen Chuanxiongqin injection (SMD = -1.9, 95% CrI: -3.7, -0.12), Ginkgo Damole injection (SMD = -2.5, 95% CrI: -4.8, -0.29), Puerarin injection (SMD = -1.8, 95% CrI: -3.2, -0.37), and Shuxuetong injection (SMD = -7.8, 95% CrI: -13, -2.3) were found to significantly reduce th
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | unstable angina pectoris and |
| Sample Size | 4362 |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- No MeSH terms indexed
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: ginkgo
Provenance
- PMID: 40144650
- DOI: 10.3389/fphar.2025.1550759
- PMCID: PMC11937076
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09